CAMPBELL BRADLEY L (President and CEO) sold 6.8% of their position (75K shares) of AMICUS THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.07M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/22/2026ACC: 0001193125-26-019838
DirectorOfficer· President and CEO
Since Mar 2026
-75K
Net shares
Net seller
$1.07M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
75K acquired · 150K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+75K
Price / share
$6.10
Trade value
$457.50K
% of position
7.3%
1/20/2026
1.02M→1.10M
Common Stock
Direct
Shares
−75K
Price / share
$14.31
Trade value
$1.07M
% of position
6.8%
1/20/2026
1.10M→1.02M
Total
Net shares
+0.00
Net value
-$615.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/20/2026 | M · Option Exercise | +75K | $6.10 | $457.50K | 7.3% | 1.02M | 1.10M |
| Common Stock Direct | 1/20/2026 | S · Sale | −75K | $14.31 | $1.07M | 6.8% | 1.10M | 1.02M |
| Total | +0.00 | -$615.68K | ||||||
Derivative Transactions1
Stock Options (right to buy)
Direct
Converts to
Common Stock
75K shares
Shares
−75K
Strike price
6.10
Held after
0.00
Exercisable
—
1/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) Direct | Common Stock75K shares | 1/20/2026 | M · Option Exercise | −75K | 6.10 | — | 0.00 |